Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain
Abstract
Authors
L.A. Vallejo-Aparicio S. Díaz-Cerezo J. Parrondo A.M. García-Aparicio